To validate the expression of ZFAS1 is indeed up-regulated in HCC patients, we measured the levels of plasma ZFAS1 in 79 control cases, 75 hepatitis B and cirrhosis patients, and 60 HCC patients by RT-qPCR. Here, ZFAS1 is linked to hepatocellular carcinoma.